Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

What Is Netflix, Inc. (NFLX)’s Market Saturation Point?

Page 1 of 2

Netflix, Inc. (NASDAQ:NFLX) today announced a deal whereby it’s getting exclusive access to 300 hundred hours of exclusive content from Dreamworks Animation Skg Inc (NASDAQ:DWA). DreamWorks Animation has a rich content collection of high-budget, high-grossing films like Shrek, Kung Fu Panda 2, Madagascar, and How to Train Your Dragon. Over the past five years the total grossing value of the films ranged from $321 million to $742 million.

Netflix, Inc. (NASDAQ:NFLX)

Neither the length of the deal nor the price of the deal was disclosed in the public announcement. Netflix will most likely disclose the amount it spent on its recent content deal when it announces earnings in the next month.

Key takeaway

Perhaps the biggest advantage to DreamWorks investors is that it provides a better monetization strategy over the long-term. The benefit of selling content to Netflix is that Netflix, Inc. (NASDAQ:NFLX) is expanding internationally, which gives DreamWorks instantaneous content redistribution, and it will market its products to consumers who may be unfamiliar to its various movie franchises. The deal is lucrative because it uses the collective buying power of Netflix’s 26.5 million paying members to pay for the redistribution of content.

Some analysts are criticizing Netflix for its almost non-existent profit margin, but the biggest benefit to this deal is that it increases the appeal of having a Netflix subscription, which may translate into higher rates of sales growth, which is a much more important metric when it comes to analyzing growth stocks.

Analysts anticipate Netflix, Inc. (NASDAQ:NFLX) to grow revenues by 20.10% in the current fiscal year; however we have no way of knowing how accurate these predictions are. This is because Netflix’s upper-management is only willing to provide guidance up to a quarter out.

Let’s not forget that Netflix has been able to beat analyst estimates by 117.87% on average over the past four quarters. The company’s recent launch of original content series and its purchase of high quality content from Time Warner Inc (NYSE:TWX)The Walt Disney Company (NYSE:DIS), and DreamWorks are putting it well ahead of its competitors. Eventually, we will enjoy original classics like Family Guy, Iron Man 3, Shrek, all for $8/month.

Netflix is trying to grow out its international streaming business, and that’s probably the reason why Disney jumped ship from Hulu in favor of Netflix, Inc. (NASDAQ:NFLX). After all Netflix’s international distribution continues to gain greater economies of scale.The Procter & Gamble Company (NYSE:PG) projects that between 2010 and 2020 the middle class will increase by 1.4 billion people, and 98% of that will come from the emerging markets alone. Internationally, I predict that the number of Internet users will increase to approximately 5 billion people by 2020. This implies that Netflix’s growth story is nowhere near over and that the company is extremely far away from market saturation.

Investment metrics

Netflix remains a lucrative investment opportunity despite all the negativity surrounding the extremely high earnings multiple. The earnings multiple is 548.6, which is high, but, on the other hand, the company is projected to grow earnings at an absurd rate over the next two years. Analysts anticipate Netflix to grow earnings by 386% in fiscal year 2013, and to follow that with 121.3% growth in 2014.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!